Clinical Trial Update: Research Study Investigating How Well Semaglutide Works in People With Type 2 Diabetes Suffering From Overweight or Obesity [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating semaglutide for weight management in people with type 2 diabetes and overweight or obesity has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Obesity, Overweight | Phase 3 | Status: COMPLETED | Results posted: 2021-08-11